Loading...
Regulatory B cells in myasthenia gravis are differentially affected by therapies
We analyzed the number and functionality of regulatory B (Breg) cells in well‐defined myasthenia gravis patients. We first showed a decreased number of circulating CD19(+) CD24(++) CD38(++) Breg cells and an altered functionality of Breg cells in untreated myasthenia gravis patients. Next, we demons...
Na minha lista:
| Udgivet i: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6243377/ https://ncbi.nlm.nih.gov/pubmed/30480034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.645 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|